Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Anne J. Novak James R Cerhan Matthew J. Maurer Brian K Link Susan L Slager Thomas E. Witzig Steven C Ziesmer |
| Publication date | June 3, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |